Lianke Liu

机构：Jiangsu Province Hospital, Nanjing Medical University

发表论文 20 篇 · 总被引 523 次 · h-index 8

代表论文

• Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12) (2021 · Journal of Thoracic Oncology · 被引 324)
• First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study (2024 · Nature Medicine · 被引 56)
• Silver Nanocrystals Mediated Combination Therapy of Radiation with Magnetic Hyperthermia on Glioma Cells (2012 · Journal of Nanoscience and Nanotechnology · 被引 29)
• Icotinib Is an Active Treatment of Non-Small-Cell Lung Cancer: A Retrospective Study (2014 · PLoS ONE · 被引 28)
• TGF-β1 induces erlotinib resistance in non-small cell lung cancer by down-regulating PTEN (2015 · Biomedicine & Pharmacotherapy · 被引 26)
• Interaction Between Hydrophobic Au Nanoparticles and Pulmonary Surfactant (DPPC) Monolayers (2018 · Journal of Biomedical Nanotechnology · 被引 18)